Oric Pharmaceuticals, Inc. - Common Stock (NQ: ORIC )
8.360
+0.090
(+1.09%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 14, 2025
Add to My Watchlist
Headline News about Oric Pharmaceuticals, Inc. - Common Stock
![](https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp)
![](https://cdn.benzinga.com/files/images/story/2025/01/14/Wall-Street-Bulls.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2025/01/10/PriceSmart.jpeg?width=1200&height=800&fit=crop)
![](https://www.marketbeat.com/logos/articles/med_20241115075031_oric-working-with-two-pharma-giants-analysts-see-1.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.png?width=1200&height=800&fit=crop)
Where ORIC Pharmaceuticals Stands With Analysts
December 13, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4.png?width=1200&height=800&fit=crop)
Analyst Expectations for ORIC Pharmaceuticals's Future
October 23, 2023
Via Benzinga
![](https://g.foolcdn.com/editorial/images/737561/research-scientists-drugs-pharma-biotech.jpg)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://cdn.benzinga.com/files/images/story/2024/04/19/Stock-Whisper-Index-Logo-6-copy.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/03/21/micron_-_logo_copy_0.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/03/12/image28.jpeg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
4 Analysts Have This to Say About ORIC Pharmaceuticals
March 23, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/02/29/image28.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/02/29/hormel_foods_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://images.pexels.com/photos/2280549/pexels-photo-2280549.jpeg?auto=compress&cs=tinysrgb&h=750&w=1260)
![](https://investorplace.com/wp-content/uploads/2022/10/stocks-to-buy-greedy1600-1024x576.png)
![](https://investorplace.com/wp-content/uploads/2019/10/medicine.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/10/26/meta_platforms_-_logo_0.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/08/15/paysafe_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2023
September 22, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/Bull,And,Bear,Are,On,A,Graphic,With,Market,Prices._1.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/08/14/22nd_century_group_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/06/26/oric.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/06/26/carnival_-logo_0.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/06/26/wolfspeed_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/07/biopharma-1600.jpg)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free